(NASDAQ: SMTI) Sanara Medtech's forecast annual revenue growth rate of 12.84% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.95%.
Sanara Medtech's revenue in 2026 is $107,509,002.On average, 5 Wall Street analysts forecast SMTI's revenue for 2026 to be $1,099,767,920, with the lowest SMTI revenue forecast at $1,050,740,686, and the highest SMTI revenue forecast at $1,141,189,060. On average, 5 Wall Street analysts forecast SMTI's revenue for 2027 to be $1,245,658,306, with the lowest SMTI revenue forecast at $1,185,451,030, and the highest SMTI revenue forecast at $1,293,127,666.
In 2028, SMTI is forecast to generate $1,423,530,944 in revenue, with the lowest revenue forecast at $1,367,630,734 and the highest revenue forecast at $1,465,318,643.